Insider · CIK 0001686138

Alkon Daniel L.

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001686138

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-16	TAOXTAO Synergies Inc.S Sale	Director, President and CSO	SSale	−19.7K sh	$1.17	−$23.1K	35,546
2022-11-15	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director, President and CSO	AAward	+75K sh	—	—	75,000
2022-11-15	TAOXTAO Synergies Inc. · Stock Option (Right to Buy)A Award	Director, President and CSO	AAward	+112K sh	—	—	112,000
2021-07-13	TAOXTAO Synergies Inc.A Award	Director, President and CSO	AAward	+43.8K sh	—	—	55,234
2021-07-13	TAOXTAO Synergies Inc.A Award	Director, President and CSO	AAward	+80K sh	—	—	91,484
2021-06-14	TAOXTAO Synergies Inc.P Purchase	Director, President and CSO	PPurchase	+10K sh	$8.26	+$82.6K	11,484
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−124K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−167K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−150K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−40K sh	—	—	0
2020-12-01	Neurotrope, Inc.Stock Option (right to buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−5,469 sh	—	—	0
2020-12-01	Neurotrope, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−29.7K sh	—	—	0
2020-11-24	Neurotrope, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000
2019-01-22	Neurotrope, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+150K sh	—	—	150,000
2017-04-11	Neurotrope, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+167K sh	—	—	167,000
2016-11-21	Neurotrope, Inc.Stock OptionA Award	See Remarks	AAward	+3.98M sh	—	—	3,976,767

Recent filings

Accepted (ET)
Dec 204
Alkon Daniel L.0001104659-22-128768
SEC(opens sec.gov)
Dec 14/A
Alkon Daniel L.0001104659-22-123800
SEC(opens sec.gov)
Dec 14/A
Alkon Daniel L.0001104659-22-123807
SEC(opens sec.gov)
Nov 174
Alkon Daniel L.0001104659-22-119879
SEC(opens sec.gov)
Jul 154
Alkon Daniel L.0001104659-21-092713
SEC(opens sec.gov)
Jun 164
Alkon Daniel L.0001104659-21-081898
SEC(opens sec.gov)
Dec 34
Alkon Daniel L.0001104659-20-132155
SEC(opens sec.gov)
Nov 274
Alkon Daniel L.0001104659-20-130080
SEC(opens sec.gov)
Jan 244
Alkon Daniel L.0001144204-19-002683
SEC(opens sec.gov)
Apr 134
Neurotrope, Inc.0001144204-17-020447
SEC(opens sec.gov)
Nov 234
Neurotrope, Inc.0001144204-16-136403
SEC(opens sec.gov)

Companies

Address

C/O NEUROTROPE, INE. 205 EAST 42ND STREET - 20TH FLOOR

NEW YORK, NY, 10017